Piga, Felisa M.

HRN: 27-13-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2026
CEFTRIAXONE 1G (VIAL)
04/11/2026
04/17/2026
IV
2g
OD
UTI
Checking Initial Appropriateness 
04/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/16/2026
04/23/2026
IV
4.5g
Q8
Intestinal Amoebiasis
Checking Initial Appropriateness 
04/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/20/2026
04/27/2026
IV
600mg
Q8H
Abscess
Checking Initial Appropriateness 
04/30/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/30/2026
05/07/2026
IV
4.5
Q8H
Abscess
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: